Literature DB >> 10667244

Recombinant cytotoxins specific for cancer cells.

W Debinski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10667244     DOI： 10.1111/j.1749-6632.1999.tb09441.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

Review 1.  Cellular and vaccine therapeutic approaches for gliomas.

Authors:  Michelle J Hickey; Colin C Malone; Kate L Erickson; Martin R Jadus; Robert M Prins; Linda M Liau; Carol A Kruse
Journal:  J Transl Med       Date:  2010-10-14       Impact factor: 5.531

2.  Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.

Authors:  Akiva Mintz; Denise M Gibo; A B Madhankumar; Nancy M Cladel; Neil D Christensen; Waldemar Debinski
Journal:  Cancer Biother Radiopharm       Date:  2008-10       Impact factor: 3.099

3.  Drug Conjugates for Targeting Eph Receptors in Glioblastoma.

Authors:  Puja Sharma; Callie Roberts; Denise Herpai; Izabela D Fokt; Waldemar Priebe; Waldemar Debinski
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-23

Review 4.  Receptor-Targeted Glial Brain Tumor Therapies.

Authors:  Puja Sharma; Waldemar Debinski
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.